BSE filing, NSE: SOURCENTRL. Summary written from the filing by ALFA Finder's alert engine.
Source Natural Foods & Herbal Supplements Ltd: key numbers
- Share price
- ₹112.95
- Market cap
- ₹72.70 Cr
- Revenue (annual)
- ₹70.38 Cr
- Net profit (annual)
- ₹3.65 Cr
- P/E (TTM)
- 19.4×Sector 46.1×
- Promoter holding
- 74.37%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Source Natural Foods & Herbal Supplements Ltd
All →Source Natural Foods & Herbal Supplements Other Announcement
Source Natural Foods filed the quarterly certificate under SEBI Regulation 74(5) confirming dematerialization activities for the period ended 30th September 2026.
Source Natural Foods & Herbal Supplements Management Change
Source Natural Foods & Herbal Supplements Limited has appointed K. B. Nambiar & Associates as new statutory auditor, following the tenure completion of Srinaga & Giridharan.
Source Natural Foods & Herbal Supplements Other Announcement
The shareholders at the 31st AGM approved the appointment of M/s. K B Nambiar & Associates as the new Statutory Auditors for a five-year term.
Source Natural Foods & Herbal Supplements Annual General Meeting
Source Natural Foods and Herbal Supplements Limited held its 31st Annual General Meeting on September 30, 2026, via video conferencing to transact various company businesses.
Source Natural Foods & Herbal Supplements Business Update
Source Natural Foods received the Ayush Quality Mark Certification from AYUSHEXCIL, recognizing its quality standards. The award reinforces confidence in its Ayurveda and herbal product manufacturing.
Source Natural Foods & Herbal Supplements Annual General Meeting
Source Natural Foods and Herbal Supplements Ltd has released its notice for the 31st Annual General Meeting and its Annual Report for the financial year 2025-26.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr